ONE-WAYOngoing theme · still written in the latest filings

Development of AKP-009 for benign prostatic hyperplasia and PCOS

An individual drug development project for AKP-009, progressing from joint development for benign prostatic hyperplasia to preparations for development for polycystic ovary syndrome (PCOS) following termination of the agreement.

Companies2How many companies write about this.

Threads2One company can carry more than one thread here.

PeriodFY2022 →Still being written about.

Directionhurts1 helps · 1 hurts · 0 flat